AGENTS DE RETICULATION ET PROCEDES ASSOCIES

• 收藏
• 分享

专利权人:

UNIVERSITY OF UTAH RESEARCH FOUNDATION

发明人:

AMBATI, BALAMURALI K.,UEHARA, HIRONORI,MUDDANA, SANTOSH

申请号：

CA3016688

公开号：

CA3016688A1

申请日:

2016.12.06

申请国别(地区):

CA

年份:

2017

代理人:

摘要：

An ophthalmic composition or dosage form can include a therapeutically effective amount of a cross-linking agent and a pharmaceutically acceptable carrier. The composition or dosage form can be used to treat an ophthalmic condition by administering a therapeutically effective amount of the composition to an eye of a subject during a treatment period.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/